Merdad Parsey
Director · 2 filings · Latest: Jun 18, 2026
ARDELYX, INC.
ArriVent BioPharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
GILD | MERDAD V PARSEY | — | Mar 3, 2025 | Proposed Sale | $115.70 | 21,910 | $2.5M | — | |
GILD | MERDAD V PARSEY | — | Jan 31, 2025 | Proposed Sale | $98.00 | 184,683 | $18.1M | — | |
GILD | MERDAD V PARSEY | — | Nov 27, 2024 | Proposed Sale | $91.92 | 164,211 | $15.1M | — | |
GILD | MERDAD V PARSEY | — | Nov 6, 2024 | Proposed Sale | $91.50 | 25,590 | $2.3M | — | |
GILD | MERDAD V PARSEY | — | Oct 1, 2024 | Proposed Sale | $83.83 | 2,000 | $167.7K | — | |
GILD | MERDAD V PARSEY | — | Sep 12, 2024 | Proposed Sale | $84.50 | 21,246 | $1.8M | — |